# FDA Inspection 1079956 - New England Baptist Hospital IRB #1 - February 01, 2019

Source: https://www.keypedia.com/records/fda_inspections/new-england-baptist-hospital-irb-1/1c4c10e5-ec80-41a9-9dab-e3b490aca264
Source feed: FDA_Inspections

> FDA Inspection 1079956 for New England Baptist Hospital IRB #1 on February 01, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1079956
- Company Name: New England Baptist Hospital IRB #1
- Inspection Date: 2019-02-01
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1079956 - 2019-02-01](https://www.keypedia.com/records/fda_inspections/new-england-baptist-hospital-irb-1/d5593803-3b4c-430a-8c8c-8c6f2decb06d)
- [FDA Inspection 820924 - 2013-02-12](https://www.keypedia.com/records/fda_inspections/new-england-baptist-hospital-irb-1/b1f63c01-4516-4e28-9b7d-db8d85a56931)
- [FDA Inspection 592368 - 2009-05-26](https://www.keypedia.com/records/fda_inspections/new-england-baptist-hospital-irb-1/97692157-9b86-4d6d-a8d5-a4766873b492)

Company: https://www.keypedia.com/companies/new-england-baptist-hospital-irb-1/491c7ef2-ca63-4f0f-8dd8-9d7d6b6ec484

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
